Exabis Library
Welcome to the e-CCO Library!
P0054: Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0055: Impact of Indole-3-Propionic Acid on Bacterial Invasion Potential of Klebsiella Strains Isolated from Pediatric Ulcerative Colitis Patients
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0056: Efficacy of Infliximab in Biologic-Experienced Patients with Inflammatory Bowel Disease: A Retrospective Study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0057: METTL3 potentiates aged CD4+T cell response via programming effector differentiation in elderly ulcerative colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0058: Modulation of early innate and adaptive immune responses in primary human intestinal tissue ex vivo
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0059: Mechanistic understanding of MB310: a consortium of gut commensal bacteria for the treatment of Ulcerative Colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P005: A multi-marker serum test to assess the presence of ulcerations in infliximab treated patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P005: Cytokine mediated intercellular communication in inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P005: Establishing a porcine model to translate anorectal stem cell organoid models to elucidate the aetiology of perianal Crohn's fistulae
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P005: Molecular-based classification of ulcerative colitis and its dynamic
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
P005: Persistent transcriptional reprogramming in the choroid plexus during chronic colitis: towards understanding persistent fatigue in patients with quiescent inflammatory bowel disease?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P005: The solute carrier LC22A4/Organic Cation Transporter (OCTN)-1 as a novel Inflammatory Bowel Disease determinant at the microbe-host interface.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P005: Variability in Vedolizumab Exposure between Patients with Inflammatory Bowel Disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P006 3D Multicellular intestine-on-a-chip model for disease modelling and drug discovery
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0060: GPR15L counteracts chronic colitis by shaping the intestinal microbiota
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0061: Guselkumab induction therapy results in molecular resolution of inflammation in moderately to severely active Ulcerative Colitis: results from the Phase 3 QUASAR induction study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0062: Circulating immune cell populations as predictive markers of vedolizumab response in Crohn disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0063: Prevalence of sarcopenia in a cohort of patients with inflammatory bowel disease: observational study in a tertiary care centre
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0064: Investigating a pathogenic role for IL-18 in Inflammatory Bowel Disease beyond the classical type 1 immunity paradigm
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0065: Circulating cell-free DNA and mitochondrial DNA differentiate disease activity in paediatric-onset inflammatory bowel disease: Interim analysis from Scotland-wide Mini-MUSIC study (2020-26)
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM